The U.S. Food and Drug Administration on Friday gave the nod to a Florida plan to import drugs from Canada at much lower prices than in the United States.
The approval could prove to be a major turning point for the United States’ prescription drug market.
U.S. residents can now buy directly from Canadian pharmacies out of their own pockets, but state Medicaid programs have not been allowed to purchase medications in bulk from Canada.
On average, U.S. drug prices are more than double those found in Canada, according to a Rand Corp. analysis.
